Specifically, METTL14 modulates IFN‐related genes (IFI27, IRS1, PSMA2, PSMA3), IL‐associated genes (CCL5, IL1B, IL32), and MHC class I genes (HLA‐A, B, C), implying a potential mechanistic link between METTL14 and cancer‐associated inflammatory responses. This evidence concerns the gene IFNA1 and cancer.